Herbal products and the liver: a review of adverse effects and mechanisms.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Gastroenterology

• Publication date

  2015-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/j.gastro.2014.12.004PMID 25500423
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Outbreak of Severe Hepatitis Linked to Weight-Loss Supplement OxyELITE Pro

  2014cited by this paper
• Liver injury from herbals and dietary supplements in the U.S. Drug‐Induced Liver Injury Network

  2014cited by this paper
• Acute Liver Failure Associated With Traditional Chinese Medicine: Report of 30 Cases From Seven Tertiary Hospitals in China*

  2014cited by this paper
• Usage of Plant Food Supplements across Six European Countries: Findings from the PlantLIBRA Consumer Survey

  2014cited by this paper
• M AN US CR IP T AC CE PT ED ACCEPTED MANUSCRIPT

  2014cited by this paper
• Low and Medium but Not High Doses of Green Tea Polyphenols Ameliorated Dextran Sodium Sulfate-Induced Hepatotoxicity and Nephrotoxicity

  2013cited by this paper
• Silibinin: an old drug in the high tech era of liver transplantation.

  2013cited by this paper
• Hepatotoxicity from anabolic androgenic steroids marketed as dietary supplements: contribution from ATP8B1/ABCB11 mutations?

  2013cited by this paper
• Causes and Outcomes of Acute Liver Failure in China

  2013cited by this paper
• Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection

  2013cited by this paper
• Cholestatic Jaundice as a Result of Combination Designer Supplement Ingestion

  2013cited by this paper
• Review article: herbal and dietary supplement hepatotoxicity

  2013cited by this paper
• Aspirin Versus Low-Molecular-Weight Heparin After Total Hip Arthroplasty

  2013cited by this paper
• Toxic hepatitis in a group of 20 male body-builders taking dietary supplements.

  2012cited by this paper
• In vivo evaluation of silybin nanosuspensions targeting liver.

  2012cited by this paper
• Cholestasis secondary to anabolic steroid use in young men

  2012cited by this paper
• Hepatoprotection of silymarin against thioacetamide-induced chronic liver fibrosis.

  2012cited by this paper
• Legalon® SIL: The Antidote of Choice in Patients with Acute Hepatotoxicity from Amatoxin Poisoning

  2012cited by this paper
• Dietary Supplement Health and Education Act

  2012cited by this paper
• Future development of global regulations of Chinese herbal products.

  2012cited by this paper
• Glycyrrhizin in patients who failed previous interferon alpha-based therapies: biochemical and histological effects after 52 weeks

  2012cited by this paper
• Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial.

  2012cited by this paper
• Legalon-SIL downregulates HCV core and NS5A in human hepatocytes expressing full-length HCV.

  2011cited by this paper
• Early drug discovery and the rise of pharmaceutical chemistry.

  2011cited by this paper
• Therapeutic effects of the oriental herbal medicine Sho‐saiko‐to on liver cirrhosis and carcinoma

  2011cited by this paper
• Treatment of hepatitis C-virus-reinfection after liver transplant with silibinin in nonresponders to pegylated interferon-based therapy.

  2011cited by this paper
• A single arm phase II study of a Far-Eastern traditional herbal formulation (sho-sai-ko-to or xiao-chai-hu-tang) in chronic hepatitis C patients.

  2011cited by this paper
• Differences in the Disposition of Silymarin between Patients with Nonalcoholic Fatty Liver Disease and Chronic Hepatitis C

  2011cited by this paper
• Continuous reporting of new cases in Spain supports the relationship between Herbalife® products and liver injury

  2011cited by this paper
• Case Definition and Phenotype Standardization in Drug‐Induced Liver Injury

  2011cited by this paper
• Crude drugs as anticancer agents.

  2011cited by this paper
• Risk of Liver Injury Associated with Chinese Herbal Products Containing Radix bupleuri in 639,779 Patients with Hepatitis B Virus Infection

  2011cited by this paper
• Great Expectations

  2011cited by this paper
• Suspected black cohosh hepatotoxicity: no evidence by meta-analysis of randomized controlled clinical trials for isopropanolic black cohosh extract

  2011cited by this paper
• Author manuscript, published in "Gastroenterology 2010;138(3):1112-22" DOI: 10.1053/j.gastro.2009.11.053 SILIBININ AND RELATED COMPOUNDS ARE DIRECT INHIBITORS OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE

  2010cited by this paper
• Standardization of nomenclature and causality assessment in drug‐induced liver injury: Summary of a clinical research workshop

  2010cited by this paper
• Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: An analytical review

  2010cited by this paper
• Use of complementary and alternative medicine by those with a chronic disease and the general population - results of a national population based survey

  2010cited by this paper
• Acute liver damage due to Serenoa repens: a case report.

  2010cited by this paper
• Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice.

  2010cited by this paper
• Hepatotoxicity Due to Hydroxycut: A Case Series

  2010cited by this paper
• Phytotherapeutics: an evaluation of the potential of 1000 plants

  2010cited by this paper
• Successful prevention of hepatitis C virus (HCV) liver graft reinfection by silibinin mono-therapy.

  2010cited by this paper
• Does MicroRNA microarray for the microsatellite status have a big translational impact?

  2009cited by this paper
• Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007.

  2009cited by this paper
• Effects of silymarin on hepatitis C virus and haem oxygenase‐1 gene expression in human hepatoma cells

  2009cited by this paper
• Severe hepatotoxicity following ingestion of Herbalife nutritional supplements contaminated with Bacillus subtilis.

  2009cited by this paper
• Severe hepatotoxicity caused by a methasteron-containing performance-enhancing supplement.

  2009cited by this paper
• Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator.

  2009cited by this paper
• Drug-Induced Liver Injury Network (DILIN) Prospective Study

  2009cited by this paper
• Hepatotoxicity from green tea: a review of the literature and two unpublished cases

  2009cited by this paper
• Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet.

  2008cited by this paper
• A 46-Yr-Old Woman With Ataxia and Blurred Vision 3 Months After Bariatric Surgery

  2008cited by this paper
• The Pharmacokinetics of Silymarin Is Altered in Patients with Hepatitis C Virus and Nonalcoholic Fatty Liver Disease and Correlates with Plasma Caspase-3/7 Activity

  2008cited by this paper
• Pharmacokinetics and Metabolic Profile of Free, Conjugated, and Total Silymarin Flavonolignans in Human Plasma after Oral Administration of Milk Thistle Extract

  2008cited by this paper
• Herbal Medicine in the United States: Review of Efficacy, Safety, and Regulation

  2008cited by this paper
• Hydroxycut hepatotoxicity: a case series and review of liver toxicity from herbal weight loss supplements.

  2008cited by this paper
• United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity

  2008cited by this paper
• Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug‐induced liver injury

  2008cited by this paper
• Cianidanol therapy for HBe-antigen-positive chronic hepatitis: a multicentre, double-blind study.

  2008cited by this paper
• Silibinin is a potent antiviral agent in patients with chronic hepatitis C not responding to pegylated interferon/ribavirin therapy.

  2008cited by this paper
• Separation and characterization of active flavonolignans of Silybum marianum by liquid chromatography connected with hybrid ion-trap and time-of-flight mass spectrometry (LC-MS/IT-TOF).

  2007cited by this paper
• Stronger Neo‐Minophagen C™, a glycyrrhizin‐containing preparation, protects liver against carbon tetrachloride‐induced oxidative stress in transgenic mice expressing the hepatitis C virus polyprotein

  2007cited by this paper
• Hepatotoxicity potential of saw palmetto (Serenoa repens) in rats.

  2007cited by this paper
• Association between consumption of Herbalife nutritional supplements and acute hepatotoxicity.

  2007cited by this paper
• Herbal does not mean innocuous: ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife products.

  2007cited by this paper
• Inhibition of T-cell inflammatory cytokines, hepatocyte NF-kappaB signaling, and HCV infection by standardized Silymarin.

  2007cited by this paper
• A study of western pharmaceuticals contained within samples of Chinese herbal/patent medicines collected from New York City's Chinatown.

  2007cited by this paper
• Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities.

  2007cited by this paper
• Herbal product use by persons enrolled in the hepatitis C Antiviral Long‐Term Treatment Against Cirrhosis (HALT‐C) Trial

  2007cited by this paper
• Acute Liver Injury Associated With the Herbal Supplement Hydroxycut in a Soldier Deployed to Iraq

  2007cited by this paper
• Pharmacology and Toxicology of Bupleurum Root-Containing Kampo Medicines in Clinical Use

  2006cited by this paper
• Fulminant hepatic failure associated with the use of black cohosh: A case report

  2006cited by this paper
• Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis).

  2006cited by this paper
• Dietary supplements in a national survey: Prevalence of use and reports of adverse events.

  2006cited by this paper
• Milk Thistle for Alcoholic and/or Hepatitis B or C Liver Diseases—A Systematic Cochrane Hepato-Biliary Group Review with Meta-Analyses of Randomized Clinical Trials

  2005cited by this paper
• Evidence for contamination of herbal erectile dysfunction products with phosphodiesterase type 5 inhibitors.

  2005cited by this paper
• Two patients with acute liver injury associated with use of the herbal weight-loss supplement hydroxycut.

  2005cited by this paper
• Herb and supplement use in the US adult population.

  2005cited by this paper
• Fulminant Liver Failure Associated with the Use of Black Cohosh

  2005cited by this paper
• Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000.

  2004cited by this paper
• Hepatitis induced by Kava (Piper methysticum rhizoma).

  2003cited by this paper
• Suppression of Ethanol and Lipopolysaccharide-induced Liver Injury by Extracts of Hydrangeae Dulcis Folium in Rats

  2003cited by this paper
• Kava lactones and the kava-kava controversy.

  2003cited by this paper
• Internet marketing of herbal products.

  2003cited by this paper
• Cytotoxicity and anti-hepatitis B virus activities of saikosaponins from Bupleurum species.

  2003cited by this paper
• Adulteration of Chinese herbal medicines with synthetic drugs: a systematic review

  2002cited by this paper
• Black cohosh and other herbal remedies associated with acute hepatitis

  2002cited by this paper
• Milk thistle for the treatment of liver disease: a systematic review and meta-analysis.

  2002cited by this paper
• Heavy metals in traditional Indian remedies

  2002cited by this paper
• Use of complementary and alternative medicine in patients with liver disease

  2002cited by this paper
• Utilization of Complementary and Alternative Medicine by United States Adults: Results From the 1999 National Health Interview Survey

  2002cited by this paper
• Long-Term Treatment of Chronic Hepatitis C with Glycyrrhizin [Stronger Neo-Minophagen C (SNMC)] for Preventing Liver Cirrhosis and Hepatocellular Carcinoma

  2002cited by this paper
• Hepatic toxicity possibly associated with kava-containing products--United States, Germany, and Switzerland, 1999-2002.

  2002cited by this paper
• Incidence and clinical features of liver injury related to Kampo (Japanese herbal) medicine in 2,496 cases between 1979 and 1999: problems of the lymphocyte transformation test as a diagnostic method.

  2002cited by this paper
• Variability in commercial ginseng products: an analysis of 25 preparations.

  2001cited by this paper
• Smoking and Abnormalities in Renal Function

  2001cited by this paper
• Kava hepatotoxicity.

  2001cited by this paper
• Genus Phyllanthus for chronic hepatitis B virus infection: a systematic review

  2001cited by this paper
• Long-Term Trends in the Use of Complementary and Alternative Medical Therapies in the United States

  2001cited by this paper

• Comparative Evaluation of Different Fruit Parts of Phyllanthus emblica L. for Functional Food Applications: Nutritional Composition, Safety, and Gut Microbiota-Associated Aging Benefits

  2026cites this paper
• Comprehensive Ethnopharmacological Analysis of Medicinal Plants in the UAE: Lawsonia inermis, Nigella sativa, Ziziphus spina-christi, Allium cepa, Allium sativum, Cymbopogon schoenanthus, Matricaria aurea, Phoenix dactylifera, Portulaca oleracea, Reichardia tingitana, Salvadora persica, Solanum lyco

  2025cites this paper
• Integrative Computational Analysis of VCX2 in Hepatocellular Carcinoma: From Potential Biomarker Discovery to Therapeutic Targeting with Peruvian Natural Products

  2025cites this paper
• Green Tea: Antioxidant vs. Pro-Oxidant Activity

  2025cites this paper
• Regulatory Mechanisms of Phenolic Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review

  2025cites this paper
• Magnetically Driven Biomimetic Microrobot Loaded with Eleutheroside B for Targeted Delivery and Neural Repair in Spinal Cord Injury.

  2025cites this paper
• Multifunctional Organoiron Dendrimers Functionalized with Zingerone: Synthesis, Characterization, and Promising Biomedical Applications

  2025cites this paper
• Hepatotoxicity of Herbal and Dietary Supplements a Review of Diagnosis, Histologic Features, and Common Culprits: Bodybuilding and Weight Loss Supplements

  2025cites this paper
• High-volume plasma exchange for acute liver failure: A retrospective study of 45 patients in Vietnam.

  2025cites this paper
• Overview of gene therapy for hemophilia: questions and answers to navigate the innovation.

  2025cites this paper
• Practice guideline for the treatment and management of iatrogenic premature ovarian insufficiency.

  2025cites this paper
• Hepatoprotective Activity and Oxidative Stress Reduction of an Arctium tomentosum Mill. Root Extract in Mice with Experimentally Induced Hepatotoxicity

  2024cites this paper
• Development of a human FaFg prediction system for polyphenols using human induced pluripotent stem cell-derived small intestinal epithelial cells.

  2024cites this paper
• Human health risk assessment of potentially toxic and essential elements in medicinal plants consumed in Zabol, Iran, using the Monte Carlo simulation method

  2024cites this paper
• Preclinical Toxicity Assessment of Polyphenols-Based Standardized Extract of Cinnamomum zeylanicum Bark

  2024cites this paper
• Silymarin Suppresses Proliferation and PD-L1 expression in Colorectal Cancer Cells and Increases Inflammatory CD8+ Cells in Tumor-Bearing Mice.

  2024cites this paper
• The Possible Side Effects of Ziziphus spina-christi Extract on the Liver, Kidneys of Female Rats

  2024cites this paper
• Natural products and dietary interventions on liver enzymes: an umbrella review and evidence map

  2024cites this paper
• The Related Mechanisms Predicted through Network-Based Pharmacological Analysis and the Anti-Inflammatory Effects of Fraxinus rhynchophylla Hance Bark on Contact Dermatitis in Mice

  2023cites this paper
• Multidrug-Resistant Acinetobacter baumannii Infections in the United Kingdom versus Egypt: Trends and Potential Natural Products Solutions

  2023cites this paper
• Safety profile of herbal medicines submitted for marketing authorization in Tanzania: a cross-sectional retrospective study

  2023cites this paper
• Natural Products in Non-alcoholic Fatty Liver Disease (NAFLD): Novel lead discovery for drug development.

  2023cites this paper
• Anti-Inflammatory Effects of Spirodela polyrhiza (L.) SCHLEID. Extract on Contact Dermatitis in Mice—Its Active Compounds and Molecular Targets

  2023cites this paper
• On Drugs

  2023cites this paper
• Natural Reno-Protective Agents against Cyclosporine A-Induced Nephrotoxicity: An Overview

  2022cites this paper
• Hawk Tea Flavonoids as Natural Hepatoprotective Agents Alleviate Acute Liver Damage by Reshaping the Intestinal Microbiota and Modulating the Nrf2 and NF-κB Signaling Pathways

  2022cites this paper
• Determination of human FaFg of polyphenols using allometric scaling.

  2022cites this paper
• A Comprehensive Review on the Use of Herbal Dietary Supplements in the USA, Reasons for Their Use, and Review of Potential Hepatotoxicity

  2022cites this paper
• Knowledge of hepatitis C and awareness of reinfection risk among people who successfully completed direct acting antiviral therapy

  2022cites this paper
• Qualitative Assessment of a Customized Anti-hepatic Herbal Formulation in Bangladesh

  2022cites this paper
• Hepatic Impact of <i>Mandragora officinarum</i> Leaf Extract on Wistar Albino Rats

  2022cites this paper
• Herbal Drug-Induced Liver Injury.

  2022cites this paper
• Role of liver sinusoidal endothelial cells in liver diseases

  2021cites this paper
• Herbal remedies, toxicity, and regulations

  2021cites this paper
• Unpredictable adverse effects of herbal products.

  2021cites this paper
• Hepatotoxicity caused by bay leaf (Laurus nobilis): A case report

  2021cites this paper
• Nutraceuticals in renal diseases

  2021cites this paper
• Nutraceuticals in hepatic diseases

  2021cites this paper
• The Effect of Mycotoxins and Silymarin on Liver Lipidome of Mice with Non-Alcoholic Fatty Liver Disease

  2021cites this paper
• Multi-Omics Integration to Reveal the Mechanism of Hepatotoxicity Induced by Dictamnine

  2021cites this paper
• Herbal and dietary supplement-induced liver injury in Taiwan: comparison with conventional drug-induced liver injury

  2021cites this paper
• Article Title: Evaluation of the Canadian Natural Health Product Regulatory Framework in Academic Research: A Scoping Review

  2021cites this paper
• African Herbal Medicines: Adverse Effects and Cytotoxic Potentials with Different Therapeutic Applications

  2021cites this paper
• Dendropanax morbifera Leaf Extracts Improved Alcohol Liver Injury in Association with Changes in the Gut Microbiota of Rats

  2020cites this paper
• Synthesis and Mechanistic Interrogation of Ginkgo biloba Chemical Space en route to (–)-Bilobalide

  2020cites this paper
• Liquid chromatography–drift tube ion mobility–mass spectrometry as a new challenging tool for the separation and characterization of silymarin flavonolignans

  2020cites this paper
• Medicinal plants and their Anti-inflammatory effects in Hepatic disorders

  2020cites this paper
• Adulteration of selected dietary supplements and their detection methods.

  2020cites this paper
• No improvement in disclosure of natural health product use to primary care medical doctors in the last 15 years: A survey of naturopathic patients.

  2020cites this paper
• Synthetic, Mechanistic and Biological Interrogation of Ginkgo biloba Chemical Space en route to (-)-Bilobalide.

  2020cites this paper
• A high-selectivity fluorescent reporter toward peroxynitrite in coexisting nonalcoholic fatty liver and drug induced liver diseases model.

  2020cites this paper
• Actualité dans l’hépatotoxicité des médicaments et autres xénobiotiques. Le rôle des compléments alimentaires

  2020cites this paper
• Presence of Mycotoxins in Milk Thistle (Silybum marianum) Food Supplements: A Review

  2020cites this paper
• Poisoning by Medical Plants.

  2020cites this paper
• Profile of herbal and dietary supplements induced liver injury in Latin America: A systematic review of published reports

  2020cites this paper
• TONGKAT ALI PLANTS OF EURYCOMA LONGIFOLIA AND STEMA TUBEROSA STIMULATE SEXUAL AROUSAL IN DOMESTIC COCKS

  2020cites this paper
• Antiviral activities of Cholistani plants against common poultry viruses.

  2020cites this paper
• Impact of Herbal and Dietary Supplements Causing Drug‐Induced Liver Injury in Latin America

  2020cites this paper
• Herbal drug discovery for the treatment of nonalcoholic fatty liver disease

  2019cites this paper
• General Discussion and Future Perspectives

  2019cites this paper
• Dietary Polyphenols and Mitochondrial Function: Role in Health and Disease.

  2019cites this paper
• Burden of liver diseases in the world.

  2019cites this paper
• Evidence for the efficacy and safety of herbal weight loss preparations.

  2019cites this paper
• ACVIM consensus statement on the diagnosis and treatment of chronic hepatitis in dogs

  2019cites this paper
• Drug-induced liver injury in obesity and nonalcoholic fatty liver disease.

  2019cites this paper
• Susceptibility-Related Factor and Biomarkers of Dietary Supplement Polygonum multiflorum-Induced Liver Injury in Rats

  2019cites this paper
• Evaluation of outcomes reported in randomized controlled trials for herbal remedies for adults with chronic hepatitis C

  2019cites this paper
• Drug-Induced Acute-on-Chronic Liver Failure in Asian Patients.

  2019cites this paper
• Role of Natural Phenolics in Hepatoprotection: A Mechanistic Review and Analysis of Regulatory Network of Associated Genes

  2019cites this paper
• Nutraceuticals in Hepatic and Pancreatic Diseases

  2019cites this paper
• Herbal medicine toxicity: The role of adulterants, contaminants and pharmacokinetic interactions

  2019cites this paper
• Poor chemical and microbiological quality of the commercial milk thistle-based dietary supplements may account for their reported unsatisfactory and non-reproducible clinical outcomes

  2019cites this paper
• Registration requirements for herbal medicines in Kuwait and internationally

  2019cites this paper
• The Development of a Database for Herbal and Dietary Supplement Induced Liver Toxicity

  2018cites this paper
• Potential adverse outcomes of herbal preparation use in childhood

  2018cites this paper
• Botanicals and Hepatotoxicity

  2018cites this paper
• Herbal and Dietary Supplement‐Induced Liver Injuries in the Spanish DILI Registry

  2018cites this paper
• Ethanol Extract of Crataegus Oxyacantha L. Ameliorate Dietary Non-Alcoholic Fatty Liver Disease in Rat

  2018cites this paper
• Hepatic Damage by Natural Remedies

  2018cites this paper
• Pharmacotherapy of Insomnia

  2018cites this paper
• Determining the Effective Substance of Prevalent Super Slim Weight Loss Capsule

  2018cites this paper
• Drug-Induced Liver Injury in Children

  2018cites this paper
• Drug-Induced and Toxic Liver Disease

  2018cites this paper
• Drugs and Toxins

  2018cites this paper
• Widespread use of herbal medicines by people living with human immunodeficiency virus and contamination of herbal medicines with antiretrovirals in Nigeria

  2018cites this paper
• Mécanismes de l’hépatotoxicité médicamenteuse

  2017cites this paper
• Development of a modified lymphocyte transformation test for diagnosing drug-induced liver injury associated with an adaptive immune response

  2017cites this paper
• Assessment of University Student's Supplements Knowledge and Educational Needs

  2017cites this paper
• Liver toxicity mechanisms of herbs commonly used in Latin America

  2017cites this paper
• Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity

  2017cites this paper
• Kidney toxicity related to herbs and dietary supplements: Online table of case reports. Part 3 of 5 series.

  2017cites this paper
• The Hazard Content of Cadmium, Lead, and Other Trace Elements in Some Medicinal Herbs and Their Water Infusions

  2017cites this paper
• Liver injury from herbal and dietary supplements

  2017cites this paper
• Phytotherapeutics: The Emerging Role of Intestinal and Hepatocellular Transporters in Drug Interactions with Botanical Supplements

  2017cites this paper
• Aloe vera-induced acute liver injury: A case report and literature review.

  2017cites this paper
• Drug-induced liver injury: Do we know everything?

  2017cites this paper
• White Paper on Natural Products

  2017cites this paper
• Intestinal and Hepatocellular Transporters: Therapeutic Effects and Drug Interactions of Herbal Supplements.

  2017cites this paper
• Liver toxicity related to herbs and dietary supplements: Online table of case reports. Part 2 of 5 series.

  2017cites this paper
• Hepatotoxicity evaluation of traditional Chinese medicines using a computational molecular model

  2017cites this paper